Sub-section menu :

Content :

Communication / Conference: Fighting counterfeit drugs - A new study carried out by Sanofi in Latin America finds high public awareness, but a mixed perception of dangers

Communication / Conference: Fighting counterfeit drugs - A new study carried out by Sanofi in Latin America finds high public awareness, but a mixed perception of dangers


Sanofi


Sanofi has been working to prevent and fighting fake medicines for nearly 10 years. This counterfeiting problem is most acute in Asia, Africa and Latin America, where it is easier to evade controls on distribution channels. In those regions, counterfeit drugs can represent up to 30% of the market.

The Internet has also become a major vector for counterfeit trafficking. For example, according to WHO, counterfeits account for 50% of medicines sold on websites that conceal their physical addresses.

Sanofi, as a partner of the 2017 France-Colombia Year, carried out a study on the perception of counterfeit medicines in Latin America: Read the press release and the study results here.


Fighting counterfeit drugs

 

IRACM

ASOP EU

Fight the fakes